Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.

CNS spectrums

Volumn 10, Issue 10, 2005, Pages

  Masand, Prakash S ^a   Culpepper, Larry ^a   Henderson, David ^a   Lee, Scott ^a   Littrell, Kimberly ^a   Newcomer, John W ^a   Rasgon, Natalie ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; ENDOCRINE DISEASE; FEMALE; HEART INFARCTION; HUMAN; HYPERPROLACTINEMIA; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRACTICE GUIDELINE; RISK FACTOR; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; METABOLIC DISEASES; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; PRACTICE GUIDELINES; RISK FACTORS; SCHIZOPHRENIA;

EID: 33644870306     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (104)